Recent evidence shows that PRMT5 is upregulated in a number of cancers, and PRMT5 is an important enzyme involved in tumorigenesis and stem cell maintenance linked to tumor progression and poor prognosis [33,34,35,36,37]. This evidence concerns the gene PRMT5 and cancer.